Araştırma Makalesi

EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS

Cilt: 4 Sayı: 11 24 Ekim 2024
PDF İndir
EN TR

EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS

Öz

Background: In medical practices worldwide, vitamin D testing is widely requested. However, the cost-effectiveness of vitamin D testing is a major concern. Many laboratories are turning to the use of clinical decision support systems (CDSS) to reduce unnecessary demand and thus the cost burden on the system. In this study, we investigated the impact of the implementation of CDSS on costs and changes in test demand before and after rationalisation of test demand. Methods: We analysed testing requests 90 days before (8 December 2018 - 8 March 2019) and 90 days after (9 March 2019 - 9 June 2019) the implementation of the CDSS in the hospital's software system. While this system completely blocked test requests from some clinics, with the exception of the intensive care unit and the ward, it allowed diagnostic requests in other clinics 90 days before (8 December 2018 - 8 March 2019) and 90 days after (9 March 2019 - 9 June 2019) implementation of CDSS in the hospital software system. The system generated a screen warning if the patient had had a vitamin D test in the previous 90 days.The Microsoft Excel pivot table tool was used to analyse test orders. The cost of the tests was compared before and after the implementation of the clinical decision support system. Results: There were 31,066 requests for 25(OH) vitamin D in the first period. There were 18,830 requests for the same analyte in the second period. This resulted in an approximately 39 percent reduction in testing requests (12,236 tests) (p<0.0001). Savings of $37,350 in three months, or an estimated annual savings of approximately $150,000. Conclusions: Incorporating CDSS into the hospital's software system resulted in a significant reduction in requests for 25(OH) vitamin D testing. The development and use of new clinical software systems in laboratories is important in terms of both resource and human workforce efficiency.

Anahtar Kelimeler

Etik Beyan

Ethics committee approval and informed consent form were not obtained for this study since the data is available to researchers and does not contain descriptive patient results

Kaynakça

  1. Lang T. Laboratory demand management of repetitive testing - Time for harmonisation and an evidenced based approach. Clin Chem Lab Med. 2013;51:1139–1140
  2. Khalifaand M, Khalid P. Reducing Unnecessary Laboratory Testing Using Health Informatics Applications: A Case Study on a Tertiary Care Hospital. Procedia Comput Sci. 2014;37:253–260
  3. Zare S, Meidani Z, Shirdeli M, Nabovati E. Laboratory test ordering in in patien thospitals: a systematic review on the effects and features of clinical decision support systems. BMC Med Inform Decis Mak. 2021;21(1):20.
  4. Roshanov PS, You JJ, Dhaliwal J, Koff D, Mackay JA, Weise- Kelly L, Navarro T, Wilczynski NL, Haynes RB; CCDSS Systematic Review Team. Can computerized clinical decision support systems improve practitioners’ diagnostic test ordering behavior? A decision-maker-researcher partnership systematic review. Implement Sci. 2011;6:88.
  5. Bridges SA, Papa L, Norris AE, Chase SK. Duplicated laboratory tests: evaluation of a computerized alert intervention abstract. J Healthc Qual. 2014;36:46-53.
  6. Gottheil S, Khemani E, Copley K, Keeney M, Kinney J, Chin-Yee I, Gob A. Reducing inappropriate ESR testing with computerized clinical decision support. BMJ Qual Improv Rep. 2016;5:u211376.w4582
  7. https://shgmlabdb.saglik.gov.tr/TR-40428/akilci-laboratuvarkullanimi-projesi-uyum-sureci-sonunda-yapilacak-olan-yerindedenetim-hakkinda-duyuru.html
  8. Tangpricha V, Spina C, Yao M, Chen TC, Wolfe MM, Holick MF. Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J Nutr. 2005;135:2350-4.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Kimya, Klinik Tıp Bilimleri (Diğer)

Bölüm

Araştırma Makalesi

Erken Görünüm Tarihi

5 Eylül 2024

Yayımlanma Tarihi

24 Ekim 2024

Gönderilme Tarihi

15 Mayıs 2024

Kabul Tarihi

1 Temmuz 2024

Yayımlandığı Sayı

Yıl 2024 Cilt: 4 Sayı: 11

Kaynak Göster

APA
Yalçınkaya Kara, Z. M., Ojalvo, D., Öztaş, B., & Serin, E. (2024). EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS. Atlas Journal of Medicine, 4(11), 137-144. https://doi.org/10.54270/atljm.2024.64
AMA
1.Yalçınkaya Kara ZM, Ojalvo D, Öztaş B, Serin E. EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS. ATLJM. 2024;4(11):137-144. doi:10.54270/atljm.2024.64
Chicago
Yalçınkaya Kara, Zeynep Mine, David Ojalvo, Berrin Öztaş, ve Erdinç Serin. 2024. “EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS”. Atlas Journal of Medicine 4 (11): 137-44. https://doi.org/10.54270/atljm.2024.64.
EndNote
Yalçınkaya Kara ZM, Ojalvo D, Öztaş B, Serin E (01 Ekim 2024) EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS. Atlas Journal of Medicine 4 11 137–144.
IEEE
[1]Z. M. Yalçınkaya Kara, D. Ojalvo, B. Öztaş, ve E. Serin, “EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS”, ATLJM, c. 4, sy 11, ss. 137–144, Eki. 2024, doi: 10.54270/atljm.2024.64.
ISNAD
Yalçınkaya Kara, Zeynep Mine - Ojalvo, David - Öztaş, Berrin - Serin, Erdinç. “EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS”. Atlas Journal of Medicine 4/11 (01 Ekim 2024): 137-144. https://doi.org/10.54270/atljm.2024.64.
JAMA
1.Yalçınkaya Kara ZM, Ojalvo D, Öztaş B, Serin E. EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS. ATLJM. 2024;4:137–144.
MLA
Yalçınkaya Kara, Zeynep Mine, vd. “EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS”. Atlas Journal of Medicine, c. 4, sy 11, Ekim 2024, ss. 137-44, doi:10.54270/atljm.2024.64.
Vancouver
1.Zeynep Mine Yalçınkaya Kara, David Ojalvo, Berrin Öztaş, Erdinç Serin. EFFECTS OF USING CLINICAL DECISION SUPPORT TOOLS ON VITAMIN D COST EFFECTIVENESS. ATLJM. 01 Ekim 2024;4(11):137-44. doi:10.54270/atljm.2024.64